Loading...

Pfizer, BioNTech COVID Vaccine Wins European Backing

December 22, 2020by Naomi Kresge and Suzi Ring, Bloomberg News (TNS)
Numbered inoculation cabins stand at the completed Covid-19 vaccination center at the Arena Berlin events venue during a visit by Federal President Frank-Walter Steinmeier on December 21, 2020 in Berlin, Germany. The vaccination center is one of six in Berlin and will likely begin offering inoculations beginning early January. The first vaccinations in Germany will likely begin December 27 with mobile teams inoculating staff and residents at nursing homes for senior citizens. (Christian Marquardt-Pool/Getty Images/TNS)

Pfizer Inc. and BioNTech SE’s COVID-19 vaccine won the backing of the European medicines regulator, clearing the way for inoculations to start before the end of the year as the continent struggles with rising death rates and tighter lockdowns.

The endorsement of the vaccine, Comirnaty, was announced in a news briefing by the European Medicines Agency on Monday. The final step in approval is a sign-off from the European Commission, expected later today.

“It is a significant step forward in our fight against this pandemic,” Emer Cooke, executive director of the agency, said in the meeting. “This is really a historic scientific achievement.”

EMA officials said there’s no evidence to suggest the vaccine won’t work against the new variant of the coronavirus that emerged in southeast England, leading to an emergency lockdown in London and causing countries including Canada, France and Germany to halt flights and suspend rail links.

European Union leaders pushed the regulator to speed up its review amid complaints that residents across the continent were still waiting to get a vaccine — pioneered in Germany — that is already being used in the U.K. and U.S. The goal is to start a European immunization campaign on Dec. 27, commission President Ursula von der Leyen said last week.

Monday’s recommendation puts the EU in position to meet that timeline. Von der Leyen said in a tweet that she expects the commission to act swiftly, with a decision by tonight.

The trials showed the vaccine was effective in preventing Covid-19 in people from 16 years of age, the agency said in a statement.

Just as Europe prepares to roll out the first vaccine, countries are suspending travel links to the U.K. amid an effort to contain a variant of the coronavirus that officials say is spreading quickly across London and southeast England.

Unlike the U.S. and U.K., which conducted emergency authorizations, the EMA reviewed the vaccine for a conditional marketing authorization. Such a decision requires more evidence, the EU commission’s directorate-general for health said last week. The EMA committee is also reviewing a similar vaccine from Moderna Inc., with a key meeting set for Jan. 6.

___

©2020 Bloomberg L.P.

Distributed by Tribune Content Agency, LLC

Health

November 26, 2021
by Dan McCue
US Restricts Travel From 8 Countries in Response to Omicron Variant

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new... Read More

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new COVID strain first detected in South Africa. The new travel restrictions, which go into effect Monday, apply to citizens of South Africa, Botswana, Zimbabwe, Namibia, Lesotho,... Read More

World Takes Action as New Variant Emerges in Southern Africa

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged... Read More

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged in Asia and Europe in reaction to news of a new, potentially more transmissible COVID-19 variant. "The last thing we need is to bring in a... Read More

November 23, 2021
by Dan McCue
House and Senate Democrats Seek to Protect Access to Birth Control Act

WASHINGTON — More than 100 Democrats in the House and Senate are urging their colleagues to help them guarantee a... Read More

WASHINGTON — More than 100 Democrats in the House and Senate are urging their colleagues to help them guarantee a woman’s timely access to birth control at her local pharmacy. The legislation, the Access to Birth Control Act, was reintroduced in the Senate Tuesday by Sens.... Read More

Biden to Have Routine Colonoscopy, Transfer Power to Harris

BETHESDA, Md. (AP) — President Joe Biden will briefly transfer power to Vice President Kamala Harris on Friday when he... Read More

BETHESDA, Md. (AP) — President Joe Biden will briefly transfer power to Vice President Kamala Harris on Friday when he undergoes a “routine colonoscopy" at Walter Reed National Military Medical Center, the White House said. Biden drove early Friday to the medical center in the Washington... Read More

November 17, 2021
by Dan McCue
Biden Administration Suspends Enforcement of Vaccine Mandate

WASHINGTON — The Biden administration on Wednesday suspended enforcement of a vaccine mandate on private companies with 100 or more... Read More

WASHINGTON — The Biden administration on Wednesday suspended enforcement of a vaccine mandate on private companies with 100 or more employees. The decision, which was carried out through the Occupational Safety and Health Administration, comes less than a week after the 5th U.S. Circuit Court of... Read More

November 17, 2021
by Alexa Hornbeck
Health Officials Address What To Do If You Lose Your Vaccination Card

WASHINGTON —Many public health departments across the country are experiencing increasing calls from individuals who have lost their vaccination cards... Read More

WASHINGTON —Many public health departments across the country are experiencing increasing calls from individuals who have lost their vaccination cards and are seeking a replacement. "Our department receives, on average, 60 requests for replacement vaccination cards each week. This number has remained steady for the last... Read More

News From The Well
Exit mobile version